@article{pmid30420752,
 author = {Pollyea, D. A.  and Stevens, B. M.  and Jones, C. L.  and Winters, A.  and Pei, S.  and Minhajuddin, M.  and D'Alessandro, A.  and Culp-Hill, R.  and Riemondy, K. A.  and Gillen, A. E.  and Hesselberth, J. R.  and Abbott, D.  and Schatz, D.  and Gutman, J. A.  and Purev, E.  and Smith, C.  and Jordan, C. T. },
 journal = {Nat Med},
 month = {12},
 note = {[PubMed Central:\hrefhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001730PMC7001730] [DOI:\hrefhttps://dx.doi.org/10.1038/s41591-018-0233-110.1038/s41591-018-0233-1] [PubMed:\hrefhttps://www.ncbi.nlm.nih.gov/pubmed/2470794024707940] },
 number = {12},
 pages = {1859--1866},
 title = {Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia},
 volume = {24},
 year = {2018}
}

